Results 91 to 100 of about 6,701,012 (264)

Health outcomes in spinal muscular atrophy type 1 following AVXS‐101 gene replacement therapy

open access: yesPediatric Pulmonology, 2018
Spinal Muscular Atrophy type 1 (SMA1) is a rare genetic neuromuscular disease where 75% of SMA1 patients die/require permanent‐ventilation by 13.6 months.
S. Al-Zaidy   +15 more
semanticscholar   +1 more source

Enzyme replacement therapy: efficacy and limitations

open access: yesItalian Journal of Pediatrics, 2018
Enzyme replacement therapy (ERT) is available for mucopolysaccharidosis (MPS) I, MPS II, MPS VI, and MPS IVA. The efficacy of ERT has been evaluated in clinical trials and in many post-marketing studies with a long-term follow-up for MPS I, MPS II, and ...
D. Concolino, F. Deodato, R. Parini
semanticscholar   +1 more source

Reality Versus Grant Application Research “Plans” [PDF]

open access: yes, 2018
This article describes the implementation of the American Indian mHealth Smoking Dependence Study focusing on the differences between what was written in the grant application compared to what happened in reality.
Addo, Ivor D.   +13 more
core   +1 more source

Metachromatic Leukodystrophy: Diagnosis, Modeling, and Treatment Approaches

open access: yesFrontiers in Medicine, 2020
Metachromatic leukodystrophy is a lysosomal storage disease, which is characterized by damage of the myelin sheath that covers most of nerve fibers of the central and peripheral nervous systems.
Alisa A. Shaimardanova   +8 more
doaj   +1 more source

Subcutaneous IgG Replacement Therapy by Push in 32 Patients with Primary Immunodeficiency Diseases in Argentine [PDF]

open access: yes, 2014
Introduction: Regular replacement with immunoglobulin infusions is the mainstay of treatment in the majority of primary immunodeficiencies. Several studies showed that Subcutaneous Immunoglobulin (SCIG) has similar efficacy to Intravenous Immunoglobulin (
Bezrodnik, Liliana   +6 more
core   +1 more source

Surfactant replacement therapy

open access: yesJornal de Pediatria, 2001
OBJECTIVE: To analyze and update information about surfactant therapy replacement in newborns with lung diseases. SOURCES: Literature review, including textbooks, meta-analyses, prospective, randomized controlled trials, retrospective assessments and case studies. Literature was reviewed based on the authors clinical and scientific experience regarding
openaire   +2 more sources

Effectiveness of additional topical antibiotics for recurrent or refractory exit-site infection: a case series

open access: yesRenal Replacement Therapy
Background Japanese peritoneal dialysis (PD) guidelines do not suggest applying mupirocin/gentamicin ointment to the exit sites of PD patients to prevent exit-site infection (ESI).
Nao Asai   +14 more
doaj   +1 more source

Hyperuricemia and prognosis in chronic kidney disease

open access: yesPočki, 2017
The ratio of uricemia, magnesia, quality of life and functional reserve of the kidneys in CKD has not been completely determined yet. These rates were analysed in 145 patients, depending on the CKD 1–5 stages.
D.D. Ivanov   +2 more
doaj   +1 more source

Intradermally delivered mRNA-encapsulating extracellular vesicles for collagen-replacement therapy

open access: yesNature Biomedical Engineering, 2023
Yi You   +29 more
semanticscholar   +1 more source

INTRAVENOUS IMMUNOGLOBULIN APPLICATION IN CLINICAL PRACTICE

open access: yesПедиатрическая фармакология, 2013
The article gives data on the structure and function of immunoglobulins. Given the multitude of mechanisms of their action, indications to their use are constantly expanding.
T. V. Latysheva, E. A. Latysheva
doaj   +1 more source

Home - About - Disclaimer - Privacy